Qube Research & Technologies LTD Evelo Biosciences, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.44 - $48.2 $14,198 - $475,252	9,860 Added 50.11%	29,537 $47,000
Q3 2022 Nov 14, 2022	SELL	$1.86 - $41.8 $20,614 - $463,269	-11,083 Reduced 36.03%	19,677 $41,000
Q2 2022 Aug 15, 2022	BUY	$1.46 - $3.55 $44,909 - $109,198	30,760 New	30,760 $65,000
Q4 2020 Feb 16, 2021	SELL	$3.91 - $12.28 $41,234 - $129,504	-10,546 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.81 - $5.73 $40,180 - $60,428	10,546 New	10,546 $56,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.